OneOme
Minneapolis, US · Founded 2013 · Delaware LLC
OneOme provides pharmacogenomic (PGx) products and services, centered on its RightMed Test that analyzes a patient's DNA to inform medication decisions. It serves health systems, payers, PBMs, employers, providers, and pharmacists with clinical consults, EHR integration, and population health tools.
BiotechDigital HealthHealthtech
Founders & leadership
DJ
Danny J. CunaginExecutive
TD
Troy D. KoposchkeExecutive
JL
John Logan Black, IIINamed on SEC filing
MJ
Matthew J. FerberNamed on SEC filing
Board
JF
Jeremy FrieseBoard director
Reported raises · per SEC filings
Form D private placements$3.8M disclosed across 4 rounds · 2015–2017
▶$100KraisedJun 2017 · 1 investors · Other TechnologyRule 506(b)
▶$100KraisedJun 2017 · 1 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Keith StewartDirector
- Harlan LangstraatExecutive Officer, Director
- Jeremy L. FrieseDirector
- Mark E. SylvesterExecutive Officer
- Troy D. KopischkeDirector
- Paul J. OwenExecutive Officer
- Offering amount
- $5M
- Amount sold
- $100K
- Minimum investment
- $50K
- Proceeds to insiders
- $960K
- First sale
- Jun 2017
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$2.1MraisedOct 2016 · 11 investors · Other TechnologyRule 506(b)
▶$2.1MraisedOct 2016 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Mark E. SylvesterExecutive Officer
- Paul J. OwenExecutive Officer
- Keith StewartDirector
- Troy D. KopischkeDirector
- Jeremy FrieseDirector
- Harlan LangstraatDirector
- Offering amount
- $3.5M
- Amount sold
- $2.1M
- Minimum investment
- $40K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$530KraisedOct 2016 · 11 investors · Other TechnologyRule 506(b)
▶$530KraisedOct 2016 · 11 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Paul J. OwenExecutive Officer
- Keith StewartDirector
- Mark E. SylvesterExecutive Officer
- Jeremy FrieseDirector
- Troy D. KopischkeDirector
- Harlan LangstraatDirector
- Offering amount
- $600K
- Amount sold
- $530K
- First sale
- Sep 2016
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
▶$1MraisedMay 2015 · 15 investors · Other TechnologyRule 506(b)
▶$1MraisedMay 2015 · 15 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- John Logan Black, IIIDirector
- Jeremy FrieseDirector
- Matthew J. FerberDirector
- Danny J. CunaginExecutive Officer
- Troy D. KoposchkeExecutive Officer, Director
- Offering amount
- $5M
- Amount sold
- $1M
- First sale
- Mar 2015
- Incorporated
- Limited Liability Company, Delaware, 2013
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 10
by search overlapGenomeweb35 shared keywordsGenomeWeb's Research Funding section publishes news coverage of research grants and government funding trends in genetics, genomics, and molecular diagnostics. It is an industry news publication serving researchers and organizations in the life sciences.
Myome34 shared keywordsMyOme uses whole genome sequencing and bioinformatics to analyze a single patient sample and produce clinically actionable reports, offering both proactive health tests (such as polygenic risk scores and medication response) and diagnostic tests for rare disease. Its genomic testing serves healthcare providers, patients, employers, and health systems to guide prevention, treatment, and lifestyle decisions.
Genomind24 shared keywordsGenomind provides pharmacogenetic testing and precision medicine software to help healthcare providers tailor medication prescriptions based on patients' genetic profiles, lifestyle, and environment. The platform integrates genetic data with clinical expertise to reduce adverse drug events and improve treatment outcomes across individual and population health settings.
One Medical21 shared keywordsNASDAQ: ONEM; acquired by Amazon
healthOme20 shared keywordsHealthHome offers Kadance, a precision cancer management service that combines genomic science with expert health navigation to help individuals with cancer risk assessment, treatment planning, and recovery. It is sold to individuals as well as insurance carriers and agents as an add-on to critical illness or life insurance policies.
Labcorp20 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
IDbyDNA19 shared keywordsScalable, high throughput DNA sequencing platforms.
Quest Diagnostics18 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.
Immunome18 shared keywordsImmunome is a clinical-stage oncology company developing targeted cancer therapies, including antibody-drug conjugates (ADCs) and small molecules, to address unmet medical needs in cancers such as lymphoma and bladder cancer. It also acquires targeted oncology assets and advances them through manufacturing and clinical development.
Nucleome18 shared keywordsNucleome develops 3D genomics technology to map genetic variants in the non-coding genome to the genes they dysregulate, with applications in understanding inflammatory diseases and discovering therapeutic targets. The company builds a data atlas of immune system dysregulation to enable development of genetically-informed therapeutics for inflammatory conditions.
Companies competing with OneOme for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does OneOme do?
- OneOme provides pharmacogenomic (PGx) products and services, centered on its RightMed Test that analyzes a patient's DNA to inform medication decisions. It serves health systems, payers, PBMs, employers, providers, and pharmacists with clinical consults, EHR integration, and population health tools.
- How much funding has OneOme raised?
- OneOme has disclosed $3.8M raised across 4 rounds.
- Where is OneOme headquartered?
- OneOme is headquartered in Minneapolis, US.